Previous 10 | Next 10 |
home / stock / emhtf / emhtf news
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it has closed the initial ...
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary It was a short week due to holidays. The Horizons Marijuana Life Sciences Index ETF ( HMLSF ) declined 4.2%, the ETFMG Alternative ...
VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has entered into a multi-year agreement (the "Agreement") with Valens GroWorks Corp. (“Valens” or “The Valens Company...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it is carrying out a financ...
Emerald Health Therapeutics, Inc. (EMHTF) Q3 2019 Earnings Conference Call December 2, 2019 10:30 a.m. ET Company Participants Bernie Hertel - IR and Communications Riaz Bandali - CEO Jenn Hepburn - CFO Conference Call Participants Ryan Tomkins - Jefferies Presentation ...
Emerald Health Therapeutics ( OTCQX:EMHTF ): Q3 GAAP EPS of -C$0.12. More news on: Emerald Health Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
VANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and nine-month period ended September 30, 2019. Full versions of the Company’s unaudited con...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it closed its prospectus s...
During the past trading week (November 25 to 29), the two co-owners of a marijuana producer in Canada have officially entered a dispute over the ownership status of the entity. A California-based multi-state operator is pulling back its expansion plans across key states, while NBA superstar ...
Emerald Health Therapeutics (TSXV: EMH ,OTCQX:EMHTF) has doubled down on its claim over half of a joint venture (JV) it created with cannabis producer Village Farms International (NASDAQ: VFF ,TSX:VFF) in the midst of a growing ownership battle. On Wednesday (November 27), Emerald released a...
News, Short Squeeze, Breakout and More Instantly...
Emerald Health Therapeutics Company Name:
EMHTF Stock Symbol:
OTCMKTS Market:
Emerald Health Therapeutics Website:
Emerald Health Therapeutics Inc (EMHTF) is expected to report for Q3 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to di...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and Skye Bioscience, Inc. (OTCQB: SKYE...